| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |